Page last updated: 2024-10-21

4,5,6,7-tetrabromo-2-azabenzimidazole and Cancer of Lung

4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Cancer of Lung in 2 studies

4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor

Research Excerpts

ExcerptRelevanceReference
"Lung cancer is a high-grade malignancy with poor 5 year-survival rates that remains incurable with current therapies."1.39Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines. ( Cheng, Q; Jia, H; Li, D; Li, L; Zhang, G; Zhao, M; Zhao, T; Zheng, J, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, T1
Jia, H1
Li, L1
Zhang, G1
Zhao, M1
Cheng, Q1
Zheng, J1
Li, D1
Scaglioni, PP1
Yung, TM1
Cai, LF1
Erdjument-Bromage, H1
Kaufman, AJ1
Singh, B1
Teruya-Feldstein, J1
Tempst, P1
Pandolfi, PP1

Other Studies

2 other studies available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Cancer of Lung

ArticleYear
Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.
    Oncology reports, 2013, Volume: 30, Issue:1

    Topics: Apoptosis; Casein Kinase II; Caspase 3; Cell Line, Tumor; Cell Survival; Cytochromes c; Humans; Lung

2013
A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Cell, 2006, Jul-28, Volume: 126, Issue:2

    Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Ca

2006